Analystreport

Blueprint Medicines Corp (NASDAQ: BPMC) was upgraded by analysts at Deutsche Bank AG from a "hold" rating to a "buy" rating.

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com